Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
Wanlong Wu, Li Guo, Yakai Fu, et al.
Clinical Reviews in Allergy & Immunology (2021) Vol. 60, Iss. 2, pp. 293-304
Closed Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
Sindhu R. Johnson, Elana J. Bernstein, Marcy B. Bolster, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 8, pp. 1182-1200
Closed Access | Times Cited: 39
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
Sindhu R. Johnson, Elana J. Bernstein, Marcy B. Bolster, et al.
Arthritis Care & Research (2024) Vol. 76, Iss. 8, pp. 1051-1069
Closed Access | Times Cited: 22
Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications
Yan Ye, Zechuan Chen, Shan Jiang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 59
Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI)
C. David, Marie‐Louise Frémond
Cells (2022) Vol. 11, Iss. 3, pp. 318-318
Open Access | Times Cited: 54
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review
Daniel Gonzalez, Latika Gupta, Vijaya Murthy, et al.
Rheumatology International (2022) Vol. 42, Iss. 9, pp. 1629-1641
Open Access | Times Cited: 48
Identification of Three Different Phenotypes in Anti–Melanoma Differentiation–Associated Gene 5 Antibody–Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease
Lingxiao Xu, Hanxiao You, Lei Wang, et al.
Arthritis & Rheumatology (2022) Vol. 75, Iss. 4, pp. 609-619
Closed Access | Times Cited: 47
Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: A meta-analysis and systematic review
Huaiya Xie, Dingding Zhang, Yuanzhuo Wang, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 62, pp. 152231-152231
Open Access | Times Cited: 23
MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)
Paula David, Saptarshi Sinha, Khizer Iqbal, et al.
EBioMedicine (2024) Vol. 104, pp. 105136-105136
Open Access | Times Cited: 15
Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model
Lei Wang, Chengyin Lv, Hanxiao You, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review
Renske G Kamperman, Anneke J. van der Kooi, Marjolein Visser, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4301-4301
Open Access | Times Cited: 34
Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China
Hanxiao You, Lei Wang, Jiajia Wang, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 3, pp. 1216-1226
Closed Access | Times Cited: 34
Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients
Jinjing Qian, Rui Li, Zhiwei Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Autoimmunity against melanoma differentiation–associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice
Yuki Ichimura, Risa Konishi, Tadatsune Iida, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 16
Closed Access | Times Cited: 7
Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management
Elena De Zorzi, Paolo Spagnolo, Elisabetta Cocconcelli, et al.
Clinical Reviews in Allergy & Immunology (2022) Vol. 63, Iss. 3, pp. 472-489
Open Access | Times Cited: 25
Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
Stefano Palmucci, A. Mari, Giovanna Cancemi, et al.
Medicina (2022) Vol. 58, Iss. 12, pp. 1757-1757
Open Access | Times Cited: 19
Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler Fibrosen
Jürgen Behr, Francesco Bonella, Björn C. Frye, et al.
Pneumologie (2023) Vol. 77, Iss. 02, pp. 94-119
Closed Access | Times Cited: 12
Exosomal miRNAs in autoimmune skin diseases
Ri Zhang, Yujia Wei, Tingmei Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Radiomics based on HRCT can predict RP-ILD and mortality in anti-MDA5 + dermatomyositis patients: a multi-center retrospective study
Wenzhang He, Beibei Cui, Zhigang Chu, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Clinical features and prognosis of anti-MDA5-positive dermatomyositis with coexistent anti-aminoacyl-tRNA synthetase antibodies
Gang Wang, Yan Dong, Chenghua Weng, et al.
Clinical Rheumatology (2025)
Closed Access
Serum KL-6 levels reflect the severity of interstitial lung disease caused by immune checkpoint inhibitors
Xiaoping Li, Dan Xue, Qiongying Wei, et al.
Immunobiology (2025) Vol. 230, Iss. 1, pp. 152866-152866
Open Access
Anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease masquerading as rheumatoid arthritis-associated interstitial lung disease or overlapping with the same: a phenomenon driven by a probable genetic predisposition
Abraham Mohan, Anjana Mohan, Anuradha Ramachandran, et al.
Clinical Rheumatology (2025)
Closed Access
Janus Kinase Inhibitor Plus Protein a Immunoadsorption in Anti-MDA5 Dermatomyositis Patients with Rapidly Progressive Interstitial Lung Disease
Yakai Fu, Zhiwei Chen, Jie Chen, et al.
(2025)
Closed Access
Identifying two pathways to poor prognosis in patients with anti-MDA5 antibodies: insights from prognostic factor and cytokines analysis
Aya Shimizu, Kazuhiro Kurasawa, Tomoka Hiyama, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access
Risk factors for progression of interstitial lung disease in Sjögren’s syndrome: a single-centered, retrospective study
Shi‐Hao He, Yu He, Kuang-Jin Guo, et al.
Clinical Rheumatology (2021) Vol. 41, Iss. 4, pp. 1153-1161
Closed Access | Times Cited: 25
Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies
Amandine Laporte, K. Mariampillai, Yves Allenbach, et al.
European Radiology (2022) Vol. 32, Iss. 5, pp. 3480-3489
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top